Insulin Aspart

This page contains recent news articles, when available, and an overview of Insulin Aspart but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.

Rapid-acting insulin analogues: Trials provide no proof of additional benefit ...  -  ‎Dec 24, 2009‎
IQWiG assessed all 3 analogue drugs approved in Germany: insulin aspart (tradename: Novorapid), insulin lispro (tradename: Humalog, Liprolog) and insulin ... Healthcanal.com

Better weight control with metformin and insulin  -  ‎Nov 11, 2009‎
All patients also received biphasic insulin aspart 70/30 (30% soluble insulin aspart and 70% intermediate acting insulin aspart) 6 units once a day before ... Endochrinology Update

Three-Year Efficacy of Complex Insulin Regimens in Type 2 Diabetes  -  ‎Oct 22, 2009‎
Patients were randomly assigned to receive one of three specific insulin regimens: 1) twice daily biphasic insulin aspart (70/30), 2) prandial insulin ... Cardiosource

Three-Year Efficacy of Complex Insulin Regimens in Type 2 Diabetes  -  ‎Oct 28, 2009‎
Patients were randomly assigned to receive biphasic insulin aspart twice daily, prandial insulin aspart three times daily, or basal insulin detemir once ... New England Journal of Medicine (subscription)

Modern insulins drive up Novo Nordisk earnings  -  ‎Oct 29, 2009‎
The firm's stable of modern insulin products, including Levemir (insulin detemir) and NovoRapid (insulin aspart) contributed 5.35 billion kroner, ... Pharma Times

Glycemic control improved after switch from oral antidiabetic drugs to BIAsp 30  -  ‎Oct 19, 2009‎
Initiating insulin therapy with insulin aspart 30/70 (BIAsp 30) improved glycemic control in insulin-naïve patients with type 2 diabetes who had poor ... Endocrine Today

Market Watch  -  ‎Nov 5, 2009‎
Insulin aspart injection (NovoLog) has undergone a label change. NovoLog can now be used in an insulin pump for up to six days. The infusion set should be ... The Hospitalist Online

מחקר: ×?יזון סוכרת ב×?מצעות טיפול ב×?ינסולין  -  ‎Nov 3, 2009‎
...המתחילי×? בטיפול בזריקות (NovoMix 30 Insulin Aspart) פע×? ביו×?, גדולה יותר ב×?ופן מובהק מבחינה סטטיסטית בהשוו×?×” לטיפול יומי בזריקות Insulin Glargine. ... דוקטורס

æ—¥ 제네릭 시장 '외ìž?사 진출러시'  -  ‎Nov 2, 2009‎
...ìš°ì„  ë‚´ë…„ì—? '노보믹스'(NovoMix, insulin aspart), '악토넬'(Actonel, risedronate), '세레벤트'(Serevent, salmeterol), '프로그ëž?'(Prograf, tacrolimus)ì?˜ 특허가 ... 디지틀보사

How effective is biphasic insulin aspart in the treatment of adolescen...  -  Apr 17, 2006
Mortensen H et al. (2006) Biphasic insulin aspart vs. human insulin in adolescents with type 1 diabetes on multiple daily insulin injections. ... Nature.com

Learn about Insulin Aspart (rDNA Origin) Injection from Consumer …  -  Jan 5, 2007
Insulin aspart is used to treat type 1 diabetes (condition in which the body does not produce insulin and therefore cannot control the amount of sugar in ... consumerreports.org

Insulin Aspart (Systemic).  -  Feb 1, 2006
Insulin aspart(IN-su-lin AS-part)is a fast-acting type of human insulin. Insulin is used by people with sugar diabetes to help keep blood sugar levels under ... Free with registration - USP DI-Volume II, Advice for the... - AccessMyLibrary.com

FDA Approves NovoLog(r) (insulin aspart [rDNA origin] injection) for ...  -  Sep 23, 2005
Novo Nordisk Inc announced today that the US Food and Drug Administration (FDA) has approved the supplemental new drug application (sNDA) of NovoLog(R) ... Medical News Today - Medical News Today (press release)

FDA Approves NovoLog(R) (Insulin Aspart [rDNA Origin] Injection) for ...  -  Sep 15, 2005
PRINCETON, NJ, Sept. 15 /PRNewswire/ -- Novo Nordisk Inc. announced today that the US Food and Drug Administration (FDA) has approved the supplemental new ... RedOrbit

Biphasic Insulin Aspart 70/30 Helps Poorly Controlled Diabetics Reach...  -  Jun 9, 2008
By Elizabeth Nicholas. SAN FRANCISCO -- June 9, 2008 -- More than two-thirds of patients with poorly controlled type 2 diabetes are able to achieve ... DG News

INSULIN ASPART, RECOMBINANT (Subcutaneous route) - IN-su-lin AS- …  -  May 1, 2007
Insulin aspartis a fast-acting type of human insulin. Insulin is used by people with type 2 diabetes to help keep blood sugar levels under control. ... Free with registration - USP DI-Volume II, Advice for the... - AccessMyLibrary.com

Insulin Aspart and Lispro Equivlent for Insulin Pumps  -  Dec 25, 2007
A group of investigators led by Dr Stuart Weinzimer of Yale University School of Medicine in New Haven, CT, USA, compared the safety and efficacy of ... Diabetes In Control

FDA Approves First Insulin Analog for Use in Insulin Pumps by...  -  Mar 18, 2008
Patients were randomised 2:1 to insulin aspart injection CSII or insulin lispro ... Nearly 60% of the participants given insulin aspart injection achieved ... DG News

insulin aspart Novo Nordisk marketed, Israel (diabetes) Novo Nordisk ...  -  Sep 26, 2005
Novo Nordisk announced on 15 September 2005 that the US FDA has approved the company's sNDA seeking approval of insulin aspart (NovoLog) for the treatment ... Pay-Per-View - R & D Focus Drug News - Factiva, from Dow Jones

… Achieve Glycaemic Control by Adding Biphasic Insulin Aspart 70/30...  -  Jun 12, 2006
WASHINGTON, DC -- June 12, 2006 -- In type 2 diabetics who are poorly controlled on 2 oral agents, the addition of biphasic insulin aspart (BIAsp) 70/30 ... DG News

… With NovoMix 30 (Biphasic Insulin Aspart) Yields Significantly...  -  Nov 7, 2005
Jain R, et al: Efficacy of biphasic insulin aspart 70/30 in patients with T2DM not achieving glycemic targets on OADs with/without basal insulin therapy. ... DG News

Nastech Announces Positive Intranasal Insulin Data at American …  -  Jun 9, 2008
In addition, the time to maximum concentration for intranasal insulin was faster (30 minutes) than for insulin aspart (90 minutes), which further ... Genetic Engineering News - Genetic Engineering News (press release)

… Nordisk Receives EU Approval for NovoMix® 30 (Biphasic Insulin...  -  May 2, 2006
Attainment of glycaemic goals in type 2 diabetes with once-, twice-, or thrice-daily dosing with biphasic insulin aspart 70/30 (The 1-2-3 study). ... DG News

Press Release: Nastech Announces Positive Phase 1 Clinical Results of...  -  Dec 6, 2006
Nastech Announces Positive Phase 1 Clinical Results of Insulin Nasal Spray Compared to Exubera(R) Inhalation Powder and NovoLog(C) Insulin Aspart Injection. Pay-Per-View - PR Newswire - HighBeam Research

… : FDA Approves NovoLog(R) (Insulin Aspart [rDNA Origin] Injection)...  -  Sep 15, 2005
FDA Approves NovoLog(R) (Insulin Aspart [rDNA Origin] Injection) for Treatment of Diabetes in Children. from PR Newswire. Highbeam Research – FREE Trial. Pay-Per-View - PR Newswire - HighBeam Research

Exenatide as Good as Insulin for Some Type 2 Diabetics: Presented at ...  -  Jun 5, 2007
The use of exenatide and biphasic insulin aspart lead to comparable reductions in A1C, with a decrease of 1.04% amongst those on exenatide and a decrease of ... DG News

Nastech Announces Positive Phase 1 Clinical Results Of Insulin Nasal ...  -  Dec 7, 2006
With respect to plasma insulin levels, rapid-acting insulin aspart injection had the highest concentration, followed by the three nasal formulations, ... Medical News Today - Medical News Today (press release)

Insulin Delivery; Release of insulin aspart from water-in-oil...  -  Mar 14, 2005
2005 MAR 14 - (NewsRx.com) -- Scientists describe the in vitro release of insulin aspart incorporated into water-in-oil emulsions in a recent issue of the ... Pay-Per-View - Diabetes Week - Factiva, from Dow Jones

American Diabetes Association 65th annual scientific sessions San...  -  Jul 1, 2005
...find Journal of Diabetes Nursing articles. Using biphasic insulin aspart (NovoLog Mix 70/30 [NovoMix 30 in the UK]; Novo Nordisk) enables most people wi... Pay-Per-View - Journal of Diabetes Nursing - HighBeam Research

Tailoring the choice of second-line regimen: personal perspectives.( …  -  Nov 1, 2008
Hb[A.sub.1c] targets reached by most biphasic insulin aspart users Using biphasic insulin aspart (NovoLog Mix 70/30 [NovoMix 30 in the UK]; Novo Nordisk) ... Pay-Per-View - Diabetes and Primary Care - HighBeam Research

… Improves Blood Sugar Levels as Effectively as Biphasic Insulin...  -  Sep 14, 2006
Patients on exenatide lost weight, while insulin aspart patients gained weight - ... Article: Biphasic insulin aspart lifesaving and cost ... ... Pay-Per-View - PR Newswire - HighBeam Research

Insulin Delivery; Release of insulin aspart from water-in-oil...  -  Mar 19, 2005
2005 MAR 19 - (NewsRx.com) -- Scientists describe the in vitro release of insulin aspart incorporated into water-in-oil emulsions in a recent issue of the ... Pay-Per-View - Obesity, Fitness & Wellness Week - Factiva, from Dow Jones

insulin aspart Novo Nordisk clinical data (diabetes).  -  Sep 25, 2006
Novo Nordisk reported on 18 September 2006 results from a study, designated PREFER, which compared the safety and efficacy of NovoMix 30 with basal-bolus ... Pay-Per-View - R & D Focus Drug News - Factiva, from Dow Jones

EASD: Early Initiation of Insulin Improves Glucose Control in Type 2 ...  -  Sep 21, 2007
Regimens using biphasic insulin or insulin aspart (prandial insulin) gave patients better control than insulin detemir (basal insulin), but these regimens ... MedPage Today

Diabetes; Researchers from the United Kingdom and United States …  -  May 10, 2006
Study 1: Insulin aspart was well tolerated and effective during long-term treatment ... According to a study from England, "Insulin aspart has been shown, ... Pay-Per-View - Life Science Weekly - Factiva, from Dow Jones

Article: Key abstract: the EUROMIX study. - Journal of Diabetes...  -  Nov 1, 2005
...find Journal of Diabetes Nursing articles. Twice-daily biphasic insulin aspart 30 plus metformin compared with once-daily insulin glargine in combinatio... Pay-Per-View - Journal of Diabetes Nursing - HighBeam Research

A patient with type B insulin resistance syndrome, responsive to...  -  Apr 4, 2007
At that time the patient was on 2600 U/day of intravenous insulin aspart. ... Whilst the patient was receiving intravenous insulin aspart and her plasma ... Nature.com

Merger and Acquisition Scenario  -  Nov 29, 2008
NovoMix 50 (Insulin Aspart Mixture); NovoLog Mix 70/30 (Insulin Aspart); NovoMix 70 (Insulin Aspart Mixture); NovoLog (Insulin Aspart (rDNA Origin)) ... $250.00 - Revere Reports - Revere

Article: Dialogue. - Journal of Diabetes Nursing | HighBeam Research ...  -  Feb 1, 2006
Study Group (2004) Comparison of Twice-Daily Biphasic Insulin Aspart 70/30 (NovoLog ... Comprising 30% soluble insulin aspart and 70% protamine-crystallised ... Pay-Per-View - Journal of Diabetes Nursing - HighBeam Research

NovoMix[R] 30 (biphasic insulin aspart): effective in treating type 2...  -  Dec 22, 2005
Over the past decade, significant advances have been made in the treatment of patients with type 2 diabetes. The risks of suboptimal control have been ... $4.95 - Diabetes and Primary Care - ECNext

Diabetes; Recent findings in diabetes described by researchers from...  -  May 3, 2006
Study 2: High levels of circulating insulin antibodies result in elevated total insulin aspart profiles after a 12-week treatment with multiple daily ... Pay-Per-View - Life Science Weekly - Factiva, from Dow Jones

Abstract and Introduction  -  Apr 10, 2007
...[16] Patients treated with insulin detemir plus insulin aspart also experienced lower within-patient variability in self-measured fasting blood glucose and ... Medscape

Merger and Acquisition Scenario  -  Nov 22, 2008
NovoLog Mix 70/30 (Insulin Aspart); NovoMix 50 (Insulin Aspart Mixture); Levemir (Insulin Detemir); NovoMix 70 (Insulin Aspart Mixture); NovoLog (Insulin ... $250.00 - Revere Reports - Revere

insulin aspart Novo Nordisk receives positive opinion for expanded...  -  Feb 28, 2005
...insulin aspart, insulin X14, INA-X14, B28-Asp-insulin, NovoRapid, NovoMix, NovoLog, A10C, Human Insulins and Analogues, Novo Nordisk. Pay-Per-View - R & D Focus Drug News - Factiva, from Dow Jones

Levemir® Approved In Europe For Use In Combination With Oral …  -  Mar 12, 2007
Insulin analogues (insulin detemir and insulin aspart) versus traditional ... Insulin detemir plus insulin aspart is associated with less risk of major as ... Medical News Today - Medical News Today (press release)

Merger and Acquisition Scenario  -  Dec 27, 2008
NovoLog Mix 70/30 (Insulin Aspart); NovoMix 50 (Insulin Aspart Mixture); Levemir (Insulin Detemir); NovoMix 70 (Insulin Aspart Mixture); NovoLog (Insulin ... $250.00 - Revere Reports - Revere

insulin aspart Novo Nordisk receives EU approval for label change.  -  May 15, 2006
Novo Nordisk announced on 2 May 2006 that the EU Commission has approved a label change for NovoMix 30, a 30/70 mixture of soluble/protamine-crystallized ... Pay-Per-View - R & D Focus Drug News - Factiva, from Dow Jones

Changing diabetes by improving control: solutions: 4-t-the evidence...  -  Oct 1, 2008
Prandial insulin aspart was marginally more effective than biphasic insulin ... Gall MA, Hancu N. Insulin detemir and insulin aspart ... regimen for type 2 ... Pay-Per-View - Journal of Diabetes Nursing - HighBeam Research

NovoMix[R] 30 (biphasic insulin aspart): effective in treating type 2...  -  Dec 22, 2005
NovoMix[R] 30 (biphasic insulin aspart): effective in treating type 2 diabetes in primary care. ... find Diabetes and Primary Care articles. Pay-Per-View - Diabetes and Primary Care - HighBeam Research

Novo Nordisk launches two insulin analogue drugs on Chinese market.( …  -  Jul 25, 2007
The Novorapid range contains insulin aspart, which is an insulin analogue, ... The other NovoRapid product contains rapid-acting insulin aspart and has a ... $4.95 - China Business News - ECNext

Exenatide As Effective As Insulin  -  Oct 10, 2006
The second group received biphasic insulin aspart (titrated to achieve an ... Weight gain in the biphasic insulin aspart: On average, patients treated with ... Diabetes In Control

FDA Approvals: Hyzaar, Levemir, NovoLog/Novolin R  -  Oct 27, 2005
Recombinant insulin aspart and human insulin were previously indicated for subcutaneous administration to control hyperglycemia in patients with diabetes ... Medscape

Mann's Inhaled Insulin Passes Big Test  -  Sep 16, 2008
A total of 293 patients received Technosphere Insulin, and 272 patients received insulin aspart. Over the 52-week period of this study, A1C levels decreased ... Medgadget.com

New publication supports once-daily use of Levemir® in type 2...  -  Sep 3, 2007
Insulin analogues (insulin detemir and insulin aspart) versus traditional human insulins (NPH insulin and regular human insulin) in basal bolus therapy for ... Healthcare Republic - Healthcare Republic

Diabetes; Findings from Wales, Germany and Denmark describe new …  -  Sep 9, 2006
Study 1: Pharmacokinetics and pharmacodynamics of biphasic insulin aspart and insulin glargine in people with type 2 diabetes are determined. ... Pay-Per-View - Obesity, Fitness & Wellness Week - Factiva, from Dow Jones

Press Release: FDA Approves NovoLog(R) Category Change for Use in …  -  Jan 30, 2007
FirstCall/ -- Diabetes patients taking NovoLog (insulin aspart [rDNA origin] ... Inc. today announced that a quantity of NovoLog(R) (insulin aspart [rDNA ... Pay-Per-View - PR Newswire - HighBeam Research

Article: Two insulin analogs work equally well in pumps.(News)  -  Mar 1, 2008
Results from previous studies have shown that both insulin lispro and insulin aspart are safe and effective for CSII in adults with type 1 diabetes, ... Pay-Per-View - Pediatric News - HighBeam Research

The day in review: TIS found as effective as insulin aspart.  -  Sep 18, 2006
...its inhaled insulin product, Technosphere insulin system (TIS), was similar in efficacy and safety to insulin aspart in patients with Type 2 diabetes. ... Pay-Per-View - Company Reports - Factiva, from Dow Jones

Article: Noticeboard.(nursing services ) - Journal of Diabetes...  -  Feb 1, 2005
This year represents the fifth birthday of NovoRapid[R] (insulin aspart), ... EMEA) approved the insulin analogue NovoRapid (insulin aspart [rDNA origin]) ... Pay-Per-View - Journal of Diabetes Nursing - HighBeam Research

Press Release: LILLY (ELI) & COMPANY - Results show exenatide …  -  Sep 14, 2006
Exenatide lowered HbA1C by 1.04 percent while biphasic insulin aspart lowered HbA1C by 0.89 ... Biphasic insulin aspart reduced mainly pre-meal glucose. ... Pay-Per-View - PR Newswire UK Disclose - HighBeam Research

International Approvals: NovoRapid, Fentanyl, Atriance  -  Sep 24, 2007
Insulin aspart is the only rapid-acting, modern insulin approved for use in ... Insulin aspart previously was approved by the EC for use in children aged 2 ... Medscape

Dialogue: Novo Nordisk receives EU approval for use of Levemir[R] ( …  -  Jul 1, 2005
Insulin analogues (insulin detemir and insulin aspart) versus ... Post-prandial administration of the insulin analogue insulin aspart in patients with Type ... $4.95 - Journal of Diabetes Nursing - ECNext

Journal of Diabetes Nursing Feb , 2006  -  Feb 1, 2006
In phase 1, 12U biphasic insulin aspart was administered within 15 minutes of dinner. This dose was self-adjusted according to self-monitored blood glucose ... $4.95 - Journal of Diabetes Nursing - ECNext

43rd annual meeting of the European association for the study of...  -  Oct 1, 2007
The regimens were as follows: biphasic insulin aspart 30 BD; mealtime insulin aspart TD; and once-daily insulin detemir. ... $4.95 - Journal of Diabetes Nursing - ECNext

Press Release: Nastech Announces Positive Phase 1 Results  -  Dec 5, 2006
With respect to plasma insulin levels, rapid-acting insulin aspart injection had the highest concentration, followed by the three nasal formulations, ... FierceBiotech

Further PREDICTIVE(R) Study Results Show Diabetes Can Be Effectively ...  -  Sep 17, 2006
Insulin analogues (insulin detemir and insulin aspart) versus traditional human insulins (NPH insulin and regular human insulin) in basal-bolus therapy for ... Medical News Today - Medical News Today (press release)

Novo Nordisk sues Sanofi-Aventis for insulin delivery device patent …  -  Sep 1, 2005
Novo Nordisk's FlexPen is the leading insulin delivery device in the United States and is used with Novo Nordisk's NovoLog Mix 70/30 (70% insulin aspart ... $4.95 - BIOTECH Patent News - ECNext

Press Release: NovoMix(R) 30 Insulin is an Effective and Safe...  -  Sep 18, 2006
The PREFER Study: both Biphasic Insulin Aspart 30 Twice-Daily and Basal-Bolus using Insulin Detemir and Insulin Aspart enabled patients with Type 2 Diabetes ... Pay-Per-View - PR Newswire Europe - HighBeam Research

International Approvals: NovoRapid, TheraCIM, Nexavar  -  Aug 7, 2006
Results of the 4-year trial revealed that use of insulin aspart significantly improved ... Compared with human insulin, use of insulin aspart also yielded ... Medscape

Are NovoLog and Humalog Interchangeable?  -  Apr 20, 2007
Insulin aspart (NovoLog, made by Novo Nordisk) and insulin lispro (Humalog, made by Eli Lilly) are rapid-acting insulin analogs indicated for treatment of ... Medscape

… the FDA for new labeling for NovoLog (insulin aspart [rDNA origin]...  -  May 12, 2008
Novo Nordisk has received approval from the FDA for new labeling for NovoLog (insulin aspart [rDNA origin] injection) for continuous subcutaneous insulin ... $9.94 - Drug Topics - Alacra Store

Switching from human insulins.(Dialogue)  -  Nov 1, 2006
Hermansen K, Fontaine P, Kukolja KK et al (2004) Insulin analogues (insulin detemir and insulin aspart) versus traditional human insulins (NPH insulin and ... $4.95 - Journal of Diabetes Nursing - ECNext

When Combined With Metformin, Premixed Insulin Analogue Is More …  -  Jun 28, 2005
Premixed insulin aspart group achieved same fasting plasma glucose reduction as insulin glargine (125 mg/dl / 7.0 mmol/l), while significantly reducing the ... Diabetes In Control

Novo Nordisk Becomes Insulin Market Leader.  -  Nov 10, 2005
This growth trend is centered around Novo Nordisk's flagship insulin products: NovoLog(R) Mix 70/30 (70% insulin aspart protamine suspension and 30 percent ... Free with registration - PR Newswire - AccessMyLibrary.com

Diabetes Control; Twice-daily insulin glargine is better for some...  -  Sep 26, 2006
2006 SEP 26 - (NewsRx.com) -- Twice-daily insulin glargine is better for some people with type 1 diabetes using meal-time insulin aspart. ... Pay-Per-View - Life Science Weekly - Factiva, from Dow Jones

FDA Approvals: Remicade, Neulasta, NovoLog  -  Sep 22, 2005
13, the FDA approved an expanded indication for insulin aspart [rDNA origin] ... The study showed that insulin aspart achieved a level of glycemic control ... Medscape

ADA: Once A Day Insulin As Effective as Multiple Injections For Type...  -  Jul 18, 2006
..."Biphasic Insulin Aspart 30 (BIAsp30), Insulin Detemir (IDet) and Insulin Aspart (IAsp) Allow Patients with Type 2 Diabetes To Reach A1C Target: The PREFER ... Diabetes In Control

Merger and Acquisition Scenario  -  Apr 7, 2007
NovoLog Mix 70/30 (Insulin Aspart); Levemir (Insulin Detemir); NovoLog (Insulin Aspart); NovoMix 50 (Insulin Aspart Mixture); NovoMix 70 (Insulin Aspart ... $250.00 - Revere Reports - Revere

Test Your Knowledge Issue 417  -  May 20, 2008
He utilizes a correction scale of 1 U insulin aspart for every 50 mg/dL (2.78 mmol/L) that his blood glucose value is above 150 mg/dL (8.32 mmol/L). ... Diabetes In Control

Insulin Analog  -  Jun 15, 2006
Another rapid-acting insulin analog called insulin aspart (marketed by Novo ... In insulin aspart, the amino acid aspartic acid replaces the amino acid ... Diabetes Self Management

STEPS - July 15, 2006 -- American Family Physician  -  Jul 15, 2006
When comparing patients with type 1 diabetes who are receiving mealtime insulin aspart with those receiving NPH insulin, insulin detemir caused slightly ... AAFP News Now

1-2-3 Study Demonstrates Efficacy of NovoLog(R) Mix 70/30 in Reaching...  -  Jun 13, 2005
SAN DIEGO, Calif., June 13 /PRNewswire/ -- NovoLog(R) Mix 70/30 (70% insulin aspart protamine suspension and 30 percent insulin aspart injection, ... RedOrbit

Rapid-acting insulin analogues in diabetes mellitus type 1 --...  -  Jul 17, 2007
Eight of these studies compared either insulin aspart or insulin lispro with human insulin; no such study was available for glulisine. ... eurekalert.org

Comparison of Insulin Detemir and Insulin Glargine in Type 1 Diabetes  -  May 22, 2007
Treatment with twice-daily insulin detemir or once-daily insulin glargine, each in combination with insulin aspart, resulted in similar glycemic control. ... Diabetes In Control

New Data Shows That The Unique Levemir Weight Benefit Continues …  -  Sep 22, 2007
Insulin analogues (insulin detemir and insulin aspart) versus traditional human insulins (NPH insulin and regular human insulin) in basal bolus therapy for ... Medical News Today - Medical News Today (press release)

Evidence Lacking For Rapid-Acting Insulin Analogues In Diabetes …  -  Jul 21, 2007
Eight of these studies compared either insulin aspart or insulin lispro with human insulin; no such study was available for glulisine. ... Medical News Today - Medical News Today (press release)

Insulin Delivery; Release of insulin incorporated into water-in-oil …  -  Mar 21, 2005
The release of the insulin analogue, insulin aspart, from water-in-oil emulsion is ... "The incorporated insulin aspart only exhibits minor secondary ... Pay-Per-View - Diabetes Week - Factiva, from Dow Jones

NovoLog OK for children using insulin pumps.  -  Apr 14, 2008
Results showed that almost 60% of patients receiving insulin aspart achieved ... Insulin aspart is a rapid-onset, short-duration insulin analog indicated to ... $9.94 - Drug Topics - Alacra Store

Insulin Delivery; Release of insulin incorporated into water-in-oil …  -  Mar 26, 2005
The release of the insulin analogue, insulin aspart, from water-in-oil emulsion is ... "The incorporated insulin aspart only exhibits minor secondary ... Pay-Per-View - Obesity, Fitness & Wellness Week - Factiva, from Dow Jones

Press Release: INITIATE Study Shows NovoLog(R) Mix 70/30 Improves …  -  Jan 27, 2005
27 /PRNewswire/ -- Novolog(R) Mix 70/30 (70% insulin aspart protamine ... Insulin Aspart 70/30 (NovoLog Mix 70/30) with Once-Daily Insulin Glargine in ... Pay-Per-View - PR Newswire - HighBeam Research

What is the role of combination therapy (insulin plus oral medication)...  -  Nov 1, 2006
An open-label RCT with 341 patients who were inadequately controlled on metformin compared beginning combination therapy (biphasic insulin aspart 30/70 ... $4.95 - Journal of Family Practice - ECNext

Coeliac disease and type 1 diabetes in a paediatric setting.(Disease/...  -  Jun 1, 2006
BG was transferred to biphasic insulin aspart (NovoMix 30; Novo Nordisk) after 3 months. * BG was subsequently moved to a three-times-daily regimen of ... $4.95 - Journal of Diabetes Nursing - ECNext

New pregnancy category for NovoLog.  -  Feb 19, 2007
The FDA has changed the Pregnancy Category rating for insulin aspart (NovoLog, ... Compared with the regular insulin, insulin aspart showed fewer preterm ... $9.94 - Drug Topics - Alacra Store

Key abstract: the EUROMIX study.  -  Nov 1, 2005
Twice-daily biphasic insulin aspart 30 plus metformin compared with once-daily insulin glargine in combination with glimepiride in type 2 diabetes. ... $4.95 - Journal of Diabetes Nursing - ECNext

Press Release: Novo Nordisk Becomes Insulin Market Leader. - PR …  -  Nov 10, 2005
This growth trend is centered around Novo Nordisk's flagship insulin products: NovoLog(R) Mix 70/30 (70% insulin aspart protamine suspension and 30 percent ... Pay-Per-View - PR Newswire - HighBeam Research

Aradigm Announces Novo Nordisk Presentation of Data of AERx Insulin …  -  Jun 14, 2005
In conclusion, inhaled insulin via the AERx(R) iDMS has an onset of action not significantly different to subcutaneous insulin aspart, but significantly ... $4.95 - PR Newswire - ECNext

Insulin Delivery; Release of insulin incorporated into water-in-oil …  -  Mar 25, 2005
The release of the insulin analogue, insulin aspart, from water-in-oil emulsion is ... "The incorporated insulin aspart only exhibits minor secondary ... Pay-Per-View - Drug Week - Factiva, from Dow Jones

Article: CSII therapy in pregnancies complicated by type 1 diabetes:...  -  May 1, 2008
Article: Study Shows Rapid-Acting Insulin Analog Insulin Aspart Equally ... ... CSII therapy with insulin aspart results ... glargine. ... Pay-Per-View - Journal of Diabetes Nursing - HighBeam Research

Press Release: GlycoMark Blood Test Included in Global Diabetes Care ...  -  Sep 25, 2007
Article: Study: Insulin aspart controls postmeal glucose ... Drug Week; January 24, 2003 ; 413 words ... ... MD, from the Sansum Medical Research Institute ... Pay-Per-View - PR Newswire - HighBeam Research

Learn How Novo Nordisks Dependency On Therapeutic Proteins And …  -  Dec 3, 2007
NovoRapid (insulin aspart) 80 Overview 80 Sales forecast 81 Newsflow 81 ... NovoMix (insulin aspart/insulin aspart protamine) 84 Overview 84 ... $4.95 - M2 Presswire - ECNext

Study Demonstrates Long-term Efficacy and Safety of NovoLog(R) Mix...  -  Jan 27, 2005
...(70% insulin aspart protamine suspension and 30% insulin aspart injection, ... and safety of biphasic insulin aspart in patients with type 2 diabetes. ... $4.95 - PR Newswire - ECNext

Article: New international guidelines focus on postprandial glucose.(N...  -  Oct 15, 2007
Article: Study: Insulin aspart controls postmeal glucose ... Drug Week; January 24, 2003 ; 413 words ...2003 JAN 24 - (NewsRx.com & NewsRx.net) -- Insulin ... Pay-Per-View - Internal Medicine News - HighBeam Research

Press Release: 1-2-3 Study Demonstrates Efficacy of NovoLog(R) Mix...  -  Jun 13, 2005
Rite Aid stores include NovoLog(R) (Insulin aspart ... Prescribing Information for NovoLog is available by contacting ... NovoPen, NovoFine, NovoLog ... Pay-Per-View - PR Newswire - HighBeam Research

Press Release: Study Demonstrates Long-term Efficacy and Safety of …  -  Jan 27, 2005
Rite Aid stores include NovoLog(R) (Insulin aspart ... Prescribing Information for NovoLog is available by contacting ... NovoPen, NovoFine, NovoLog ... Pay-Per-View - PR Newswire - HighBeam Research

Type I diabetes, dialysis and insulin pump therapy.(Case study)  -  Feb 1, 2005
Initially her insulin aspart dose taken with lunch was reduced, but this had to be omitted when she experienced severe hypoglycaemic events while on ... $4.95 - Journal of Diabetes Nursing - ECNext

Merger and Acquisition Scenario  -  Mar 11, 2006
Levemir (Insulin Detemir); Velosulin (Human Insulin); NovoMix 70 (Insulin Aspart Mixture); NovoMix 50 (Insulin Aspart Mixture); NovoLog (Insulin Aspart) ... $250.00 - Revere Reports - Revere

Federal Register 2006 - 71 FR 5863 Summaries of Medical and Clinical ...  -  Feb 3, 2006
...and NOVOLOG (insulin aspart). These summaries are being made available consistent with the Best Pharmaceuticals for Children Act (the BPCA). ... Pay-Per-View - Federal Register 2006 - Loislaw

Management of diabetes-related hypoglycemia.(Review Article)(Disease/...  -  Feb 1, 2007
...(12) Premixed insulin aspart 70/30 or premixed insulin lispro 75/25 contain a soluble fraction of a rapid-acting insulin analog and a crystallized fraction ... Free with registration - Southern Medical Journal - AccessMyLibrary.com

Novo Nordisk Receives EU Approval of NovoMix 50 and NovoMix 70 …  -  Oct 11, 2005
J2. ain R, et al: Efficacy of biphasic insulin aspart 70/30 in patients with T2DM not achieving glycemic targets on OADs with/without basal insulin therapy. ... DG News





Health Home | Conditions | Cancer | Medications | Surgery | Vaccines


The Cancer News Network


Disclaimer:

Contact a physician with regard to health concerns. Email requests for further health information will be discarded.

The materials contained on this Web site are for informational purposes only and do not constitute health or medical advice. Use of information on this site does not create or constitute any kind of agreement or contract between you and the owners or users of this site, the owners of the servers upon which it is housed, or anyone else who is in any way connected with this site.

Many links on cancernewsnetwork.org lead to other sites. cancernewsnetwork.org does not sponsor, endorse or otherwise approve of the materials appearing in such sites. Nor is CancerNewsNetwork.org responsible for dead or misdirected links.

IF YOU NEED A LINK OR TEXT REMOVED FROM THIS PAGE PLEASE CONTACT cancernewsnetwork (at) live.com.
We will do our best to accommodate your request.



COPYRIGHT 2009 CANCERNEWSNETWORK | Privacy